ARCHIVES

Successful Treatment by Community MDs Reducing Numbers Of Patients In Research, DCT Board Told; “We can Work With them,” Carbone Says

This article is from The Cancer Letter archive.

Vol. 05 No. 17 | April 27, 1979

Download PDF Visit The Full Archive

Related Articles

FDA Approves Avastin Combination For Late-Stage Cervical Cancer

August 29, 2014

DCT Board Approves Phase 2/3 Studies Of LAK-IL-2

February 14, 1986

CAM Therapies Should Be Held to Conventional Standards and Congress Should Toughen Dietary Supplements Act, IOM Panel Says.

January 21, 2005

House Panel Provides NCI $1.7 Billion for 1991, Expects Greater Emphasis On Cancer Prevention

July 20, 1990

FDA Approves Velcade Injection In Mantle Cell Lymphoma

October 31, 2014

Data Presented At Scientific Meetings Can Have Impact On Patient Treatment

March 31, 2006